Device company Teleflex Inc. has announced the FDA 510(k) clearance of its Arrow® FlexBlock continuous peripheral nerve block catheter.
The Arrow FlexBlock continuous peripheral nerve block catheter is intended for clinicians who use ultrasound guidance when placing continuous peripheral nerve block catheters. The echogenic, coil-reinforced FlexBlock catheter body is constructed of polyurethane, and the unique catheter design offers a combination of ultrasound visibility, flexibility, and excellent kink resistance. The FlexBlock catheter’s tip design is intended to provide clinicians with a predictable spread of anesthetic.
“Teleflex is pleased to be adding the ARROW FlexBlock catheter to our market-leading1 line of ARROW® StimuCath® continuous peripheral nerve block catheters,” said Cary Vance, President, Teleflex Anaesthesia and Respiratory. “These products, in addition to the StimuQuik® ECHO peripheral nerve block needles, SureBlock® spinal trays, and the recently 510(k) cleared FlexTip Plus® Multi-Port epidural catheters, give Teleflex a clinically differentiated regional anaesthesia product portfolio, designed to meet the needs of anaesthesiologists in the field of regional anaesthesia and acute pain management.”
Note: Arrow, FlexBlock, FlexTip Plus, StimuCath, StimuQuik, SureBlock, and Teleflex are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.
1. IMS Market Data, Q1 2011
Source: Teleflex, Inc., Business Wire